Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
about
Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectivesPharmacogenomics in the clinicComparison of delivery strategies for pharmacogenetic testing servicesA health-care system perspective on implementing genomic medicine: pediatric acute lymphoblastic leukemia as a paradigmPharmacogenomics of chemotherapeutic susceptibility and toxicityPharmacogenomics in diverse practice settings: implementation beyond major metropolitan areasTreatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychoticsChallenges to integrating pharmacogenetic testing into medication therapy managementAn ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-careMedical student preparedness for an era of personalized medicine: findings from one US medical schoolElectronic Medical Record-Integrated Pharmacogenomics and Related Clinical Decision Support Concepts.Pharmacogenomic characterization of gemcitabine response--a framework for data integration to enable personalized medicine.Effects of Using Personal Genotype Data on Student Learning and Attitudes in a Pharmacogenomics CourseCharacterizing Pharmacogenomic-Guided Medication Use With a Clinical Data Repository.An inter-professional approach to personalized medicine education: one institution's experienceIntegrating clinical decision support systems for pharmacogenomic testing into clinical routine - a scoping review of designs of user-system interactions in recent system development.Making Meaningful Clinical Use of BiomarkersPharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties.Metformin pharmacogenomics: current status and future directions.Personalized medicine and genetic malpractice.Clinical implementation of germ line cancer pharmacogenetic variants during the next-generation sequencing era.Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral responsePharmacogenomics and individualized medicine: translating science into practice.Pharmacogenetics in clinical practice: how far have we come and where are we going?Key challenges for next-generation pharmacogenomics: Science & Society series on Science and Drugs.Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information.Diffusion of molecular diagnostic lung cancer tests: a survey of german oncologistsPhysician Attitudes toward Adopting Genome-Guided Prescribing through Clinical Decision Support.Personalizing health care: feasibility and future implications.Ethical, legal and social implications of incorporating personalized medicine into healthcare'Someday it will be the norm': physician perspectives on the utility of genome sequencing for patient care in the MedSeq ProjectPharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.Do physicians think genomic medicine will be useful for patient care?"Getting off the Bus Closer to Your Destination": Patients' Views about Pharmacogenetic TestingScenario drafting for early technology assessment of next generation sequencing in clinical oncologyDifferences in Weight Loss Between Persons on Standard Balanced vs Nutrigenetic Diets in a Randomized Controlled Trial.A survey of physician receptivity to molecular diagnostic testing and readiness to act on results for early-stage colon cancer patients.Preemptive clinical pharmacogenetics implementation: current programs in five US medical centersCurrent State and Future Prospects of Direct-to-Consumer PharmacogeneticsPersonalized medicine - where do we stand? Pouring some water into wine: a realistic perspective
P2860
Q26741009-651476A6-BEA3-44D6-B8B8-045A8858318BQ26782786-5D4B1F0B-AC19-40D5-BC03-038665D821F6Q26860925-90C553B7-02A8-4032-9DF2-5FF786D33B7BQ26866379-F395E553-AE84-45A4-8235-B6269DD96ACCQ27025558-EBF72021-77A5-4CE0-8DC2-43F1E89BD1BEQ27335306-802AD161-C04F-48B1-AB08-EDA35349B4B2Q28079065-7BDA34E2-3073-471E-A58C-6B1974640DF5Q28082835-B6AC5E7F-E8A4-4A08-921D-F55922C7D733Q28538389-0BEDA0F0-C0F3-4181-8245-C86155B34C06Q30151843-6D93FE36-9CE8-4AF6-AE26-82A7ABA8BE38Q30234897-41C6AD35-C93A-436D-8114-12CF7E51359EQ30728815-EF281455-207E-4317-BF0F-417F3EDD2589Q31137602-FF1ACAF5-A620-436B-B617-4CB95336F003Q31153959-6A6868D2-0730-40B6-AB9C-BDB2237B87CEQ33565033-AC4FB1FF-7904-40A6-974C-86C7B71891B3Q33771344-D9D1BA66-BD5C-4415-BF86-1340449533E5Q33821481-FE743620-81F1-460C-A3CD-8ABE98FD480FQ33910107-3DD14519-D80A-4C4E-8C5E-A1FAC786C97CQ33959731-FA769441-829E-4B18-A059-1052E1CD5B19Q33998136-19E089CE-2F4C-4735-A244-C25A3FFDC939Q34026161-DE95D28A-0DD7-4BE0-8ABC-5D42E7CE1E4FQ34173696-C68D3727-3CC1-401D-8A93-9F5ABF451A74Q34297575-9E7A7035-126B-4537-81CF-1EEC8CF904B1Q34343365-01F0B573-50C0-448E-826E-D8E699D62DD2Q34407941-0A256815-EA17-4B46-ADF7-6606CBCFEB45Q34608756-3E7A1DD7-F062-4C95-AAC1-2172E3B12DE8Q34608778-57ACF626-BF8C-4023-A011-6E2127C9D852Q34608790-B8DD41CE-47BC-431D-BDB1-481B43E25B53Q34938911-914C3FCA-B088-4146-A73E-9A436780B874Q34977421-E368F65B-0CCD-453A-976D-A9F3F9580C39Q35012563-40E9B177-A33E-433A-874A-B72D7CC4707AQ35812195-031CD6B2-2F6E-4476-A608-6506EC75E555Q35827874-99EB1084-2C93-4FBA-B03F-EEC31BC841FEQ35846470-4A243D37-145A-4DE0-82A3-25EA14DE1C99Q35916535-154CAC95-01AC-48A5-AD04-548E159F58FDQ35988480-E5C30D35-C633-452D-B1BF-FE620793C03CQ36156776-64016FE9-1F5C-4215-8CA6-FDF7D5E69EC3Q36166107-34D03D72-00B0-44C9-B270-FE3973D5492CQ36174824-76F21A59-C9FD-44BB-8FD7-ACB28C52AD41Q36193093-4CC01011-8120-4455-8128-769DB2D8B499
P2860
Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
@ast
Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
@en
Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
@nl
type
label
Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
@ast
Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
@en
Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
@nl
prefLabel
Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
@ast
Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
@en
Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
@nl
P2093
P2860
P356
P1476
Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
@en
P2093
B C Agatep
C L Sanders
E J Stanek
K A Johansen Taber
R E Aubert
R R Verbrugge
R S Epstein
P2860
P304
P356
10.1038/CLPT.2011.306
P407
P577
2012-01-25T00:00:00Z